Kyle Chiang Logic Bio Therapeutics, Inc. (LOGC) insider trading activity

LOGC Quotes by TradingView

Kyle Chiang is Chief Operating Officer of LogicBio Therapeutics, Inc.. Currently has a direct ownership of 23,387 shares of LOGC, which is worth approximately $0. The most recent transaction as insider was on Apr 16, 2021, when has been sold 2,977 shares (Common Stock) at a price of $5.73 per share, resulting in proceeds of $17,058. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.4K
0% 3M change
0% 12M change
Total Value Held $0

Kyle Chiang Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 16 2021
SELL
Open market or private sale
$17,058 $5.73 p/Share
2,977 Reduced 11.29%
23,387 Common Stock
Apr 15 2021
BUY
Exercise of conversion of derivative security
-
9,360 Added 26.2%
26,364 Common Stock
KC

Kyle Chiang

Chief Operating Officer
Lexington, MA

Track Institutional and Insider Activities on LOGC

Follow LogicBio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LOGC shares.

Notify only if

Insider Trading

Get notified when an Logic Bio Therapeutics, Inc. insider buys or sells LOGC shares.

Notify only if

News

Receive news related to LogicBio Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LOGC